Published in Medical Devices and Surgical Technology Week, February 13th, 2005
"Most stem cell research and development currently is concentrated on cellular therapeutics as opposed to the delivery of stem cells. Our subsidiary is confident that stem cell research, its applications, and specifically the necessary targeted delivery, will expand exponentially in the near future," said LifeStem president Dan Fulkerson, who...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.